1145PResponses and durability of clinical benefit in triple negative breast cancer patients treated with pegilodecakin monotherapy or in combination with platinum plus taxane-based chemotherapy.
Saved in:
| Title: | 1145PResponses and durability of clinical benefit in triple negative breast cancer patients treated with pegilodecakin monotherapy or in combination with platinum plus taxane-based chemotherapy. |
|---|---|
| Authors: | Naing, A1 (AUTHOR), Autio, K A2 (AUTHOR), Falchook, G S3 (AUTHOR), Meric-Bernstam, F1 (AUTHOR), Litton, J K4 (AUTHOR), Ibrahim, N K4 (AUTHOR), Hung, A5 (AUTHOR), Oft, M6 (AUTHOR), Leveque, J7 (AUTHOR), Patel, M R8 (AUTHOR) |
| Source: | Annals of Oncology. 2018 Supplement, Vol. 29, pN.PAG-N.PAG. 1p. 1 Chart. |
| Database: | Academic Search Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 133286775 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: 1145PResponses and durability of clinical benefit in triple negative breast cancer patients treated with pegilodecakin monotherapy or in combination with platinum plus taxane-based chemotherapy. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Naing%2C+A%22">Naing, A</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Autio%2C+K+A%22">Autio, K A</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Falchook%2C+G+S%22">Falchook, G S</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Meric-Bernstam%2C+F%22">Meric-Bernstam, F</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Litton%2C+J+K%22">Litton, J K</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Ibrahim%2C+N+K%22">Ibrahim, N K</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Hung%2C+A%22">Hung, A</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Oft%2C+M%22">Oft, M</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Leveque%2C+J%22">Leveque, J</searchLink><relatesTo>7</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Patel%2C+M+R%22">Patel, M R</searchLink><relatesTo>8</relatesTo> (AUTHOR) – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Annals+of+Oncology%22">Annals of Oncology</searchLink>. 2018 Supplement, Vol. 29, pN.PAG-N.PAG. 1p. 1 Chart. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=133286775 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1093/annonc/mdy288.018 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 1 StartPage: N.PAG Titles: – TitleFull: 1145PResponses and durability of clinical benefit in triple negative breast cancer patients treated with pegilodecakin monotherapy or in combination with platinum plus taxane-based chemotherapy. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Naing, A – PersonEntity: Name: NameFull: Autio, K A – PersonEntity: Name: NameFull: Falchook, G S – PersonEntity: Name: NameFull: Meric-Bernstam, F – PersonEntity: Name: NameFull: Litton, J K – PersonEntity: Name: NameFull: Ibrahim, N K – PersonEntity: Name: NameFull: Hung, A – PersonEntity: Name: NameFull: Oft, M – PersonEntity: Name: NameFull: Leveque, J – PersonEntity: Name: NameFull: Patel, M R IsPartOfRelationships: – BibEntity: Dates: – D: 04 M: 10 Text: 2018 Supplement Type: published Y: 2018 Identifiers: – Type: issn-print Value: 09237534 Numbering: – Type: volume Value: 29 Titles: – TitleFull: Annals of Oncology Type: main |
| ResultId | 1 |
